Eadie M J, Bochner F, Hooper W D, Tyrer J H
Clin Exp Neurol. 1978;15:131-44.
The pharmacokinetics of methylphenobarbitone and phenobarbitone were studied following the administration of methylphenobarbitone on a chronic basis in 77 patients, and after a single dose to each of 4 subjects who had received no other drugs and 4 subjects who had been pretreated with various anticonvulsants and other agents. At steady-state, plasma phenobarbitone concentrations correlated better with methylphenobarbitone dose than did plasma methylphenobarbitone concentrations. In this group the ratio of plasma phenobarbitone level to plasma methylphenobarbitone level was in the range of 7 to 10:1. In the single dose studies, mean values of elimination rate constant (0.0155h) and clearance (1.85L/h) for untreated subjects were different from those for the pretreated subjects (0.0375h and 5.10L/h), while the apparent volumes of distribution did not differ significantly between the two groups (120.3L vs 140.8L). The data are interpreted as most probably indicating induction of hepatic microsomal enzymes in the pretreated group.
对77例长期服用甲基苯巴比妥的患者以及4例未服用过其他药物的受试者和4例预先使用过各种抗惊厥药及其他药物的受试者单次服用甲基苯巴比妥后,研究了甲基苯巴比妥和苯巴比妥的药代动力学。在稳态时,血浆苯巴比妥浓度与甲基苯巴比妥剂量的相关性比血浆甲基苯巴比妥浓度更好。在该组中,血浆苯巴比妥水平与血浆甲基苯巴比妥水平之比在7至10:1范围内。在单次给药研究中,未治疗受试者的消除速率常数(0.0155h)和清除率(1.85L/h)的平均值与预先治疗受试者(0.0375h和5.10L/h)不同,而两组之间的表观分布容积无显著差异(120.3L对140.8L)。这些数据最有可能解释为预先治疗组中肝微粒体酶被诱导。